SCHEMBL8365993

SCHEMBL8365993

O=C(OC(S)CS)OC(S)CS

nearest known ligand 0.32

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
PTGS1 P23219 1/20 0.32
SLC7A11 Q9UPY5 1/20 0.32
KDM4E B2RXH2 1/20 0.31
MAPT P10636 1/20 0.31
THRB P10828 1/20 0.31
ALOX15 P16050 1/20 0.31
NFKB1 P19838 1/20 0.31
PTGS2 P35354 1/20 0.31
THPO P40225 1/20 0.31
RECQL P46063 1/20 0.31
BLM P54132 1/20 0.31
SMN1; SMN2 Q16637 1/20 0.31
NR1I2 O75469 1/20 0.30
ALDH1A1 P00352 1/20 0.30
LMNA P02545 1/20 0.30
CYP1A2 P05177 1/20 0.30
HTT P42858 1/20 0.30
HSD17B10 Q99714 1/20 0.30
TDP1 Q9NUW8 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL722539 0.97 PTGS1 (0.31) PTGS1SLC7A11KDM4EMAPTTHRB
SCHEMBL10711654 0.78
Potassium Ion SCHEMBL28427961 0.76
SCHEMBL449640 0.72
SCHEMBL268056 0.71 ACE (0.31)
SCHEMBL4854159 0.69
SCHEMBL10834897 0.69
SCHEMBL3983465 0.69
SCHEMBL487338 0.69
Ammonia Solution, Strong SCHEMBL10415819 0.69

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0686203-A4 COMPOUNDS AND METHODS FOR THE DIAGNOSIS, TREATMENT AND PREVENTION OF DISEASES OF CELL DEATH GEN HOSPITAL CORP (US) 1999-08-25 EP claimed
EP-0686203-A1 COMPOUNDS AND METHODS FOR THE DIAGNOSIS, TREATMENT AND PREVENTION OF DISEASES OF CELL DEATH THE GENERAL HOSPITAL CORPORATION (US) 1995-12-13 EP claimed
WO-1994019493-A1 COMPOUNDS AND METHODS FOR THE DIAGNOSIS, TREATMENT AND PREVENTION OF DISEASES OF CELL DEATH THE GENERAL HOSPITAL CORPORATION (US) 1994-09-01 WO claimed
EP-0678030-A1 USE OF SULPHATED POLYSACCHARIDES FOR PREVENTING SEXUALLY TRANSMITTED DISEASES THE POPULATION COUNCIL (US) 1995-10-25 EP disclosed
WO-1994015624-A1 USE OF SULPHATED POLYSACCHARIDES FOR PREVENTING SEXUALLY TRANSMITTED DISEASES THE POPULATION COUNCIL (US) 1994-07-21 WO disclosed